Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
AB Science S.A
ABCurrent price
0.93 EUR
-0.003 EUR (-0.32%)
Last closed
0.94 EUR
Company
www.ab-science.com
ISIN
FR0010557264
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Euronext Paris
Capitalization
63 836 650 EUR
Yield for 12 month
-65.67 %
1Y
3Y
5Y
10Y
15Y
AB
AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France. Address: 3, avenue George V, Paris, France, 75008
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
18.08 EURP/E ratio
–Dividend Yield
–Current Year
+981 263 EUR
Last Year
+969 125 EUR
Current Quarter
+566 502 EUR
Last Quarter
+264 031 EUR
Current Year
+593 816 EUR
Last Year
+937 764 EUR
Current Quarter
+271 112 EUR
Last Quarter
+181 079 EUR
Key Figures AB
1 year
3 years
5 years
10 years
EBITDA
-8 681 653 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-18.16 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
18.08 EUR
Revenue TTM
1 094 564 EUR
Book Value
-0.42 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
25 %
Dividend Yield
–
Gross Profit TTM
937 764 EUR
Earnings per share
-0.071 EUR
Diluted Eps TTM
-0.071 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics AB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
65.152
Price Sales TTM
58.3215
Enterprise Value EBITDA
-25.974
Price Book MRQ
–
Financials AB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AB
For 52 weeks
0.89 EUR
4.52 EUR
50 Day MA
1.01 EUR
Shares Short Prior Month
–
200 Day MA
1.65 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart